Literature DB >> 8261396

Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.

R Lubin1, B Schlichtholz, D Bengoufa, G Zalcman, J Trédaniel, A Hirsch, C Caron de Fromentel, C Preudhomme, P Fenaux, G Fournier, P Mangin, P Laurent-Puig, G Pelletier, M Schlumberger, F Desgrandchamps, A Le Duc, J P Peyrat, N Janin, B Bressac, T Soussi.   

Abstract

p53 antibodies have been found in sera of patients with breast and lung carcinomas and in children with B-lymphomas. We report here the presence of p53 antibodies in sera of patients with 11 different types of cancer. The frequency of seropositives for p53 varied among the different types of cancer, but a correlation with the frequency of p53 gene alteration was established. Using a powerful peptide enzyme-linked immunosorbent assay, we demonstrated that the immune response of patients with p53 antibodies was restricted to a small subset of peptides localized in the amino and carboxy termini of p53, whatever the type of cancer. Given the similarities of the patterns of immune responses in patients with p53 antibodies and animals hyperimmunized with human p53, we propose that the p53 humoral response is the result of a self-immunization process which is itself the consequence of p53 protein accumulation in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261396

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

Authors:  E M Tan
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.

Authors:  P Hammel; B Boissier; M T Chaumette; P Piedbois; N Rotman; J C Kouyoumdjian; R Lubin; J C Delchier; T Soussi
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

3.  Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.

Authors:  Takashi Himoto; Hirohito Yoneyama; Kazutaka Kurokohchi; Michio Inukai; Hisashi Masugata; Fuminori Goda; Reiji Haba; Seishiro Watanabe; Shoichi Senda; Tsutomu Masaki
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

Review 4.  Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors:  E M Tan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

Review 5.  Serum markers of hepatocellular carcinoma.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Massimiliano Berretta; Alessandro Cappellani; Mariano Malaguarnera
Journal:  Dig Dis Sci       Date:  2010-03-26       Impact factor: 3.199

Review 6.  A systematic review of humoral immune responses against tumor antigens.

Authors:  Miriam Reuschenbach; Magnus von Knebel Doeberitz; Nicolas Wentzensen
Journal:  Cancer Immunol Immunother       Date:  2009-06-28       Impact factor: 6.968

7.  Humoral immune response to p53 in malignant glioma.

Authors:  M Weller; A Bornemann; M Ständer; M Schabet; J Dichgans; R Meyermann
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

8.  New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study.

Authors:  Satoshi Yajima; Takashi Suzuki; Yoko Oshima; Fumiaki Shiratori; Kimihiko Funahashi; Shinichi Kawai; Toshihiro Nanki; Sei Muraoka; Yoshihisa Urita; Yoshihisa Saida; Shinichi Okazumi; Yuko Kitagawa; Yuki Hirata; Hirotoshi Hasegawa; Koji Okabayashi; Masahiko Murakami; Takeshi Yamashita; Rei Kato; Hisahiro Matsubara; Kentaro Murakami; Yasuaki Nakajima; Hironobu Sugita; Martin Klammer; Hideaki Shimada
Journal:  Ann Surg Oncol       Date:  2020-11-18       Impact factor: 5.344

9.  p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

Authors:  J Roth; D Dittmer; D Rea; J Tartaglia; E Paoletti; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.

Authors:  Benjamin Piura; Ettie Piura
Journal:  J Oncol       Date:  2010-01-17       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.